Wordt geladen...
High expression levels of erythropoietin and its receptor are not correlated with shorter survival in human glioblastoma
Erythropoietin (EPO) is used to treat anemia in neoplastic disease. EPO also exerts neuroprotective effects on neuronal cells, making a prophylactic use against the neurocognitive effects of radiochemotherapy probable. However, EPO/EPO-receptor (EPOR) signalling has been also detected in glioblastom...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2011
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3440671/ https://ncbi.nlm.nih.gov/pubmed/22977501 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2011.198 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|